Profile picture

Professor Pavel Jansa

First Faculty of Medicine and General Teaching Hospital, Prague (Czechia)
Follow
Logo ESC

Contributor content

Macitentan tadalafil Fixed Dose Combination (FDC) in treatment-naive and prior monotherapy patients with Pulmonary Arterial Hypertension (PAH): insights from A DUE
Presentation
Macitentan tadalafil Fixed Dose Combination (FDC) in treatment-naive and prior monotherapy patients with Pulmonary Arterial Hypertension (PAH): insights from A DUE
Read more
Q&A/discussion and meeting close - Optimizing patient care: a state-of-the-art update on pulmonary hypertension management.
Presentation
Q&A/discussion and meeting close - Optimizing patient care: a state-of-the-art update on pulmonary hypertension management.
Read more
PAH: defining the current clinical challenges.
Presentation
PAH: defining the current clinical challenges.
Read more

ESC 365 is supported by

novartis Explore sponsored resources